3.6K
Articles
59.9K
Citations
3.2
avg. Impact Factor
96
h-index

Most Cited Articles of Division of Medical Oncology and Hematology in 2015

TitleJournalYearCitations
Expanding global access to radiotherapyLancet Oncology, The2015457
Spatial genomic heterogeneity within localized, multifocal prostate cancerNature Genetics2015306
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyLancet Oncology, The2015229
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015Annals of Oncology2015220
Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year ExperienceEuropean Urology2015178
A systematic review of factors influencing older adults' decision to accept or decline cancer treatmentCancer Treatment Reviews2015152
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitorsAnnals of Oncology2015139
The clinical significance of hypoxia in human cancersSeminars in Nuclear Medicine2015133
Pembrolizumab2015131
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancerAnnals of Oncology2015129
Survivorship and Quality of Life in Head and Neck CancerJournal of Clinical Oncology2015129
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysisEuropean Urology2015129
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus statusCancer2015109
525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028European Journal of Cancer201599
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancerAnnals of Oncology201597
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activationProceedings of the National Academy of Sciences of the United States of America201595
International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal MelanomaJAMA Ophthalmology201594
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trialsAnnals of Oncology201592
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillanceCancer Medicine201587
A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatmentOral Oncology201584
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancerOncotarget201584
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticleJournal of Controlled Release201583
Aprepitant and fosaprepitant: a 10-year review of efficacy and safetyOncologist201579
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumJournal of Enzyme Inhibition and Medicinal Chemistry201579
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant studyBreast Cancer Research201576